4
Changes in Ownership
CORCEPT THERAPEUTICS INC Filed Acc 0000950170-23-058943
Chief Accounting Officer sold 5,000 shares at an average $28.10 ($140,520)
- Chief Accounting Officer acquired 5,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Lyon Joseph Douglas Chief Accounting Officer | 2023-11-01 | Option exercise 10b5-1 | +1,023 | $11.35 | $11,611 | 6,877 | D |
| Lyon Joseph Douglas Chief Accounting Officer | 2023-11-01 | Sale 10b5-1 | −1,023 | $28.08 | $28,726 | 5,854 | D |
| Lyon Joseph Douglas Chief Accounting Officer | 2023-11-02 | Option exercise 10b5-1 | +3,977 | $11.35 | $45,139 | 9,831 | D |
| Lyon Joseph Douglas Chief Accounting Officer | 2023-11-02 | Sale 10b5-1 | −3,977 | $28.11 | $111,794 | 5,854 | D |
| Derivatives | |||||||
| Lyon Joseph Douglas Chief Accounting Officer | 2023-11-01 | Option exercise · Stock option (right to buy) 10b5-1 | −1,023 | 53,144 | D | ||
| Lyon Joseph Douglas Chief Accounting Officer | 2023-11-02 | Option exercise · Stock option (right to buy) 10b5-1 | −3,977 | 49,167 | D | ||
| Open-market sales · 5,000 sh · avg $28.10 · $140,520 | |||||||
Loading xslF345X05/ownership.xml…